Wound down in-person blood-draw services in Singapore while making the U.S. the primary home; company says Singapore dashboards and accounts remain accessible.
SourceBloodwork and personalized insights to help you live longer
Public company, workplace, funding, and market signals
YC S24 preventive-health company selling an at-cost lab-testing marketplace plus clinician-reviewed guidance, AI concierge support, and longitudinal biomarker tracking; expanded from Singapore to the U.S. and now serves customers across all 50 states.
Primary product
At-cost lab testing marketplace and preventive-health membership with Mito Concierge
Founded
2023
Headquarters
San Francisco, California, United States
Team size
10-20
Industry
Hospitals and Health Care
Sub-industry
Preventive health / longevity diagnostics
Offices
0 jobs at Mito Health
Check back later for new openings
Business model
Stage
Seed
Total raised
$4.1M
Latest round
Seed · Mar 2025
Latest amount
$2.2M
Leadership
Co-Founder & CEO
Co-Founder & CTO
Chief Medical Officer
Care Team Lead
Founders
Co-Founder & CPO
Investors
Transparent, patient-first, and prevention-oriented; public messaging emphasizes no upsells, honest pricing, clinician-reviewed guidance, and evidence-based care.
Compensation
No official compensation bands were found. A third-party Beamstart listing showed a Head of Growth role at roughly $100k-$150k/year, but this is not confirmed by Mito Health.
Benefits
Pricing
$9/month membership plus pay-as-you-go published lab pricing; non-members can buy tests without a subscription, and consults are add-ons.
Differentiators
Technology
Customers
Competitors
Estimated revenue
$1M-$10M
Estimated monthly visits
154.9K
Traffic estimate as of Jun 2026
Wound down in-person blood-draw services in Singapore while making the U.S. the primary home; company says Singapore dashboards and accounts remain accessible.
SourceKenneth Lou on LinkedIn · Jul 2026
Launch of seven curated at-home kits covering heart, hormones, TRT, weight, and longevity; emphasizes transparent pricing and that not all tests can be done at home.
Mito Health · Jan 2026
Official announcement that the U.S. is now the primary home, Kenneth Lou relocated to San Francisco, and in-person Singapore blood-draw services were wound down.
Longevity.Technology · Mar 2025
Longevity-focused coverage of the seed round, the company’s biomarker-driven preventive-health product, and its use of AI plus clinician review.
Vulcan Post · Mar 2025
Coverage of the funding announcement, investor list, and the company’s U.S. expansion while winding down in-person blood draws in Singapore.
Mito Health · Mar 2025
Company announcement of a $2.2M seed round, bringing total funding to about $4M and naming new and existing investors; also notes U.S. expansion plans.